Capabilities of Perinatal Healthcare Institutions in the Federation of Bosnia and Herzegovina
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT06039618 |
Recruitment Status :
Completed
First Posted : September 15, 2023
Last Update Posted : September 18, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Prenatal Care | Other: Referral to Centre of Higher Organizational Level |
Study Type : | Observational |
Actual Enrollment : | 22897 participants |
Observational Model: | Case-Control |
Time Perspective: | Cross-Sectional |
Official Title: | Capabilities of Perinatal Healthcare Institutions in Primary and Tertiary Care of Low Birth Weight Infants in the Federation of Bosnia and Herzegovina: A Cross-sectional Multicentric Study. |
Actual Study Start Date : | January 1, 2013 |
Actual Primary Completion Date : | December 31, 2017 |
Actual Study Completion Date : | December 31, 2017 |
Group/Cohort | Intervention/treatment |
---|---|
Referred to a Centre of Higher Level
Those are the newborns that were referred at the time of delivery or within one week after birth to centers of higher organizational level.
|
Other: Referral to Centre of Higher Organizational Level
Referral to Centre of Higher Organizational Level. This means referral from a primary neonatal care center to a secondary one, or from the secondary to the tertiary center. |
Treated at the Centre of Admission
Those are the newborns that were not referred to other centers and were treated in the health facility were the birth took place, and hospitalized in the same center until discharge.
|
- Referral to a centre of higher organizational level. [ Time Frame: Before birth and up to 4 hours or more after delivery. ]Referring the neonate with low birth weight to a more specialized centre.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 22 Weeks to 42 Weeks (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Newborns of both genders that were born in the maternity wards in 10 cantons of the FBiH
- A gestational age between 22 and 42 weeks, and a birth weight less than 2500g.
Exclusion Criteria:
- Infants younger than 22 weeks or older than 42 weeks.
- Infants whose mothers refused to give consent for participation in the study.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06039618
Bosnia and Herzegovina | |
General Hospital Tešanj | |
Tešanj, Bosnia and Herzegovina |
Principal Investigator: | Anis Cerovac, M.D. | General Hospital Tešanj |
Responsible Party: | Antoine Naem, Research Assistant, Evangelisches Krankenhaus Bethesda zu Duisburg |
ClinicalTrials.gov Identifier: | NCT06039618 |
Other Study ID Numbers: |
02-09/2-77/20 |
First Posted: | September 15, 2023 Key Record Dates |
Last Update Posted: | September 18, 2023 |
Last Verified: | September 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |